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Abstract: Platycodon grandiflorum (Campanulaceae) is used as traditional medicine in 
Asian countries. In Korean traditional medicine, Platycodon root has been widely used 
since ancient times as a traditional drug to treat cold, cough and asthma. However, its 
effects on bone marrow-derived mast cell (BMMC)-mediated allergy and inflammation 
mechanisms remain unknown. In this study, the biological effect of Platycodon root 
ethanol extract (PE) was evaluated in BMMC after induction of allergic mediators by 
phorbol 12-myristate 13-acetate (PMA) plus calcium ionophore A23187 (A23187) 
stimulation. The effect of PE on the production of several allergic mediators, such as 
interleukin-6 (IL-6), prostaglandin D2 (PGD2), leukotriene C4 (LTC4), β-Hexosaminidase 
(β-Hex) and cyclooxygenase-2 (COX-2) protein, was investigated. The results demonstrate 
that PE inhibits PMA + A23187 induced production of IL-6, PGD2, LTC4,  
β-Hexosaminidase and COX-2 protein. Taken together, these results indicate that PE has 
the potential for use in the treatment of allergy. 
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1. Introduction 
Platycodon root is the root of Platycodon grandiflorum, which belong to the family of 
Campanulaceae. In Asian countries, Platycodon root has been widely used since ancient times as a 
traditional drug. More specifically, it is often prescribed as a folk remedy and herbal medicine for 
coughs, sputum, asthma and tonsillitis disorder effects. Recent studies have shown that materials 
derived from Platycodon root are effective against asthma, have anti-inflammatory effects and act 
against fatty liver [1-3]. 
Mast cells are one of the most important cells for diseases related to allergic. When activated, mast 
cells release a number of biologically active molecules through various processes. Histamine, 
serotonin and serine proteases are released through exocytosis, lipid mediators such as eicosanoids are 
released through the activation of the cyclooxygenase-2 and 5-lipoxygenase (LOX) pathways and 
various cytokines are synthesized de novo [4-6]. They have long been implicated in the pathology and 
mortality of anaphylaxis and other allergic disorders by virtue of both their ability to be activated 
through FcεRI-bound antigen-specific IgE and their concentration at surfaces that interface with the 
external environment [4]. Mast cells may also be activated by various cytokines through cytokine 
receptors. Activation through any of these cytokine receptors leads to release of a number of 
biologically active molecules, including histamine, serotonin, proteoglycans and neutral proteases. 
Among these molecules, histamine is one of the most important chemical mediators in the pathologic 
allergic reaction [7]. 
Interleukin-6 (IL-6) is an interleukin that acts as both a pro-inflammatory and anti-inflammatory 
cytokine. It is secreted by T cells and macrophages to stimulate immune response to trauma, especially 
burns or other tissue damage leading to inflammation [8,9].
 Further, IL-6 modulates a variety of 
physiological events on the nervous system, endocrine system and bone metabolism [9,10]. 
Cyclooxygenase (COX) is a bi-functional enzyme that first catalyzes the addition of two molecules 
of oxygen to arachidonic acid to form the hydroperoxide prostaglandin G2 (PGG2), then reduces the 
hydroperoxide to the alcohol, PGH2, by a peroxidase activity [11]. It has two isoforms, COX-1 and 
COX-2. COX-1, which is constitutively expressed in most cells,is responsible for the production of 
prostaglandins that maintain homeostasis. In contrast, COX-2 is upregulated in inflammatory cells in 
response to an inflammatory stimulus and is responsible for the production of prostaglandins at the site 
of inflammation [12-15].
 Therefore, there is an increasing interest in the use of COX-2 inhibitors. 
In the present study, the ability of Platycodon root ethanol extract (PE) to suppress phorbol   
12-myristate 13-acetate (PMA) and calcium ionophore A23187 (A23187)-induced IL-6, PGD2, LTC4 
production and COX-2 protein expression in BMMC was investigated. The results show that PE has 
anti-allergic activity. Int. J. Mol. Sci. 2010, 11                 
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2. Results and Discussion 
2.1. The Effects of PE on BMMC Viability 
Allergy is a disorder of the immune system often also referred to as atopy. Allergic reactions occur 
to normally harmless environmental substances known as allergens; these reactions are acquired, 
predictable, and rapid. Strictly, allergy is one of four forms of hypersensitivity and is called type I 
hypersensitivity. It is characterized by excessive activation of mast cells and basophils by a type of 
antibody known as IgE, resulting in an extreme inflammatory response [16]. The cytotoxic effect of PE 
was evaluated in BMMC by MTS assay (see Section 3). Figure 1 shows that treatment with PE at 
concentrations of up to 1000 μg/mL did not affect the viability of BMMC. 
Figure 1. Effect of PE on BMMC viability. The cell viability of BMMC was assessed 
using an MTS assay following incubation with different doses (100 or 1000 μg/mL) of PE 
for 24 h. Values are the mean ± S.E. of duplicate determinations from three separate 
experiments. 
 
 
2.2. The Effects of PE on PMA and A23187-Induced IL-6 Secretion 
IL-6 is released in a coordinated network and plays an important role in chronic disease. As such, 
the pattern of cytokine expression largely determines the nature and persistence of the inflammatory 
response [17]. IL-6 is a potent mediator of inflammatory processes, and a pleiotropic inflammatory 
cytokine produced by T cells, macrophages, monocytes, and synovial fibroblasts. To evaluate the 
effect of PE on the production of IL-6, we pretreated cells with PE (100 or 1000 μg/mL) before 
stimulation with PMA (50 nM) and A23187 (1 μM) for 6 h, followed by analysis using ELISA. As 
shown in Figure 2, the level of IL-6 considerably increased after stimulation with PMA plus A23187 
in BMMC. Pretreatment of cells with PE (100 or 1000 μg/mL) inhibited these increases in a 
concentration-dependent and statistically significant manner. Int. J. Mol. Sci. 2010, 11                 
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Figure 2. Effect of PE on the secretion of IL-6 in PMA + A23187-stimulated BMMC. 
BMMCs (1  10
6 cells/mL) were pretreated with PE (100 or 1000 μg/mL) 30 min prior to 
stimulation with PMA (50 nM) and A23187 (1 μM). 6 h after PMA + A23187 stimulation, 
the IL-6 level of the supernatants were measured by ELISA. Statistical significance:   
*P < 0.05, as compared to the PMA + A23187 treated group. Significant differences 
between treated groups were determined using the Dunnett’s t-test. Values shown are the  
mean ± S.E. of duplicate determinations from three separate experiments. 
 
 
2.3. The Effects of PE on PMA and A23187-Induced PGD2 Production 
BMMC exhibit biphasic PGD2 biosynthetic responses over time, in addition to COX-1-dependent 
immediate and COX-2-dependent delayed responses [18]. The immediate PGD2 generation occurring 
within 2 h is associated with the coupling of COX-,1 and the delayed PGD2 generation, which occurs 
after several hours of culturing (between 2-10 h), is associated with the de novo induction and function 
of COX-2 after stimulation with particular stimuli [18]. This cell model also appears to be suitable for 
assessing the effect of 5-LOX inhibitors, since the immediate LTC4 generation elicited by the   
IgE-dependent or cytokine-initiated stimulus occurs in BMMC through 5-LOX [19]. Therefore, the 
BMMC system is useful for screening selective COX-1/COX-2 or 5-LOX and COX-2/5-LOX dual 
inhibitors from various sources [20,21]. After stimulation with PMA + A23187, cell-cultured mediums 
were harvested to measure the level of PGD2 production. PGD2 production was clearly detected 2 h 
after stimulation with PMA + A23187. PGD2 production also peaked in PMA (50 nM) + A23187  
(1 μM). Next, an investigation of the inhibitory effect of PE on the PMA + A23187 induced PGD2 
production in BMMC was performed. Figure 3 shows PE significantly inhibited PMA plus A23187-
induced PGD2 production in dose-dependent manner. These results show that PE can inhibit PMA plus 
A23187 induced PGD2 production in BMMC.
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Figure 3. Effect of PE on the production of PGD2 in PMA + A23187-stimulated BMMC. 
BMCCs (1  10
6 cells/mL) were pretreated with PE (100 or 1000 μg/mL) 30 min prior to 
stimulation with PMA (50 nM) + A23187 (1 μM). 2 h after PMA + A23187 stimulation, 
the PGD2 levels of the supernatants were measured by ELISA. Statistical significance:  
*P < 0.05, as compared to the PMA + A23187 treated group. Significant differences 
between treated groups were determined using the Dunnett’s t-test. Values shown are the  
mean ± S.E. of duplicate determinations from three separate experiments. 
 
 
2.4. The effects of PE on PMA and A23187-Induced LTC4 Production 
Arachidonic acid can also be converted to leukotrienes (LTs) by the action 5-lipoxygenase (LOX) 
in BMMC. The inhibition of 5-LOX is believed to be the ideal treatment for allergic diseases and 
asthma [22]. Therefore, the inhibitory activity of PE on the generation of LTC4 in the BMMC was 
examined. Figure 4 shows that the BMMC stimulated with PMA + A23187 for 15 min produced 
approximately 2.3 ng/mL LTC4, and preincubation of the BMMC with PE resulted in the   
dose-dependent suppression of this LTC4 biosynthesis. After stimulation with PMA plus A23187,   
cell-cultured mediums were harvested to measure the level of LTC4 production. LTC4 production was 
clearly detected 15 min after stimulation with PMA + A23187. LTC4 production also peaked in PMA 
(50 nM) plus A23187 (1 μM). Next, an investigation of the inhibitory effect of PE on the PMA and 
A23187 induced LTC4 production in BMMC was performed. Figure 4 shows PE significantly 
inhibited PMA plus A23187-induced LTC4 production in dose-dependent manner. These results show 
that PE can inhibit PMA + A23187 induced LTC4 production in BMMC. 
2.5. The Effects of PE on PMA and A23187-Induced COX-2 Protein Expression 
COX-2 is strongly induced in various activated cells. It has been reported that PGD2, which is the 
COX-2 metabolite released from activated mast cells, is also essential for the pathogenesis of 
eosinophilic airway [23]. The inhibitory effect of the PE on PGD2 production was examined to 
determine if it is a direct effect of the COX-2 protein or if this inhibition is mediated by some other 
mechanism. Western blot analysis was performed to determine if the inhibitory effect of PE on PGs Int. J. Mol. Sci. 2010, 11                 
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were related to modulation of the COX-2 protein expression. As shown in Figure 5, the COX-2 protein 
was not detected in unstimulated BMMC. However, in response to PMA plus A23187, COX-2 protein 
was strongly expressed, and COX-2 protein expression was inhibited in a dose-dependent manner  
by PE.  
Figure 4. Effect of PE on the production of LTC4 in PMA + A23187-stimulated BMMC. 
BMMCs (1  10
6 cells/mL) were pretreated with PE (100 or 1000 μg/mL) 30 min prior to 
stimulation with PMA (50 nM) + A23187 (1 μM). 15 min after PMA + A23187 
stimulation, the LTC4 levels of the supernatants were measured by ELISA. Statistical 
significance: *P < 0.05, as compared to the PMA + A23187 treated group. Significant 
differences between treated groups were determined using the Dunnett’s t-test. Values 
shown are the mean ± S.E. of duplicate determinations from three separate experiments. 
 
 
Figure 5. Effects of PE on PMA + A23187-induced COX-2 protein expressions in BMMC. 
BMMC were pretreated with the indicated concentrations of PE for 30 min prior to 
incubateion with PMA (50 nM) + A23187 (1 μM) for 6 h. Equal amounts of protein   
(20  μg) were then separated by SDS-polyacrylamide gel electrophoresis and 
immunoblotted with COX-2 antibodies. Equal loading of protein was verified by β-actin. 
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2.6. The Inhibitory Effects of PE on PMA and A23187-Induced Degranulation 
When mast cells are activated by various stimuli, the release of histamine bears a close parallel to 
that of β-Hex, which is one degranulation marker [24]. An investigation of the effect of PE on the 
PMA p+ A23187-induced β-Hex release was performed using ELISA. As shown in Figure 6, 
pretreatment of BMMC with PE at concentrations of 100 or 1000 μg/mL reduced β-Hex production. 
Figure 6. Effect of PE on the release of β-Hexosaminidase in PMA + A23187-stimulated 
BMMC. BMMC (1  10
6 cells/mL) were pretreated with PE (100 or 1000 μg/mL) 30 min 
prior to stimulation with PMA (50 nM) + A23187 (1 μM). 90 min after PMA + A23187 
stimulation, the β-Hex released into the supernatant cell lysate was measured by ELISA. 
The procedure is described in Materials and Methods in detail. All data are the arithmetic 
mean of triplicate determinations. Statistical significance: *P < 0.05, as compared to the 
PMA plus A23187 treated group. Significant differences between treated groups were 
determined using the Dunnett’s t-test. Values shown are the mean ± S.E. of duplicate 
determinations from three separate experiments. 
 
 
2.7. High Performance Liquid Chromatography (HPLC) 
HPLC analysis of saponins from Platycodon root was carried out on a Hitachi L-6200 instrument 
equipped with an evaporative light scattering detection (ELSD) system and SIL-9A auto injector 
(Shimadzu, Japan). A Zorbax SB-Aq C18 column (150  4.6 mm, 5 μm particle size) from Agilent 
Technologies (Palo Alto, CA, USA) was used for all separations. HPLC conditions were as follows: 
eluent A, water; eluent B, acetonitrile; gradient, 0-6 min (10-15% B), 6-50 min (15-25% B), 50-60 min 
(25-47.5% B), and then equilibrated with 10% B for 8 min at a flow of 1 mL/min. The ELSD was set 
to a probe temperature of 70 °C, a gain of 7 and the nebulizer gas nitrogen adjusted to 2.5 bar. As 
shown in Figure 7, peaks were assigned by comparing their retention times with that of each reference 
compound eluted in parallel with a series of mobile phase and by spiking sample with reference 
compounds. The standard solutions containing 2-400 μg/mL corresponding to test ranges of 10 
saponins were prepared in triplicate and 50 μL of each sample was injected into the HPLC column for 
the construction of calibration curves and linear ranges. The calibration curves were plotted by the Int. J. Mol. Sci. 2010, 11                 
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peak area versus concentration of each analyte. The linearity was evaluated by linear regression 
analysis calculated by the least square regression method. 
The samples used in the previous experiment was purchased at a local herbal market and originated 
from China. In addition, the sample was extracted with 100% methanol [25]. In this experiment, the 
roots were collected in Korea and were extracted with 70% ethanol. These differences between the 
samples might affect the variation of saponin composition (Table 1). 
Figure 7. HPLC Chromatograms of PE. 
 
Table 1. Content of each compound. 
Number Name  μg/mg 
1 Deapi-Platycoside  E  1.4694 
2 Platycoside  E  1.6027 
3 Deapi-Platycodin  D3 ND 
4 Platycodin  D3 1.3450 
5 Deapi-Platycodin  D  1.6375 
6 Platycodin  D  5.6279 
7 Polygalacin  D  6.3629 
8 3"-O-acetyl polygalacin D  2.3310 
9 Platycodin  A  2.7392 
10 2"-O-acetyl polygalacin D  2.3579 
3. Experimental Section 
3.1. Plant Materials 
Platycodon roots were collected from JinAn, Korea, in February, 2009. They were identified by Dr. 
D.Y. Kwon. A voucher specimen was deposited in the Laboratory of Herbalogy, College of Pharmacy, Int. J. Mol. Sci. 2010, 11                 
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Wonkwang University, Iksan, Korea. The dried aerial parts of the Platycodon roots (1 kg) were cut 
into small pieces and extracted repeatedly with 70% ethanol. The solution was filtered and evaporated 
in vacuo to yield a powered extract (177.4 g). 
3.2. Animals 
Male Balb/cJ mice (20-30 g) were purchased from DAMUL, Korea. All animals were kept in a 
temperature controlled room under a 12 h light/ 12 h dark cycle. The animals were provided with free 
access to commercial solid food (SCF Co., Ltd. Korea) and water ad libitum. Mice were acclimatized 
for at least one week prior to beginning the experiments. 
3.3. Drugs and Chemicals 
RPMI 1640, penicillin and streptomycin and FBS (Fetal Bovine Serum) were obtained from 
Hyclone (Hyclone Labs Logan, UT). Bovine serum albumin (BSA), PMA and A23187 were purchased 
from Sigma (St. Louis, MO, USA). COX-2 and β-actin monoclonal antibodies and peroxidase 
conjugated secondary antibody were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA). 
3.4. Preparation and Activation of Bone Marrow-Derived Mast Cells (BMMC) 
Bone marrow mast cells from male Balb/cJ mice were cultured for up to 10 weeks in 50% enriched 
medium (RPMI 1640 containing 2 mM L-glutamine, 0.1 mM nonessential amino acids, antibiotics, 
and 10% fetal bovine serum) and 50% WEHI-3 cell-conditioned medium as a source of IL-3. After 3 
weeks, >98% of the cells were BMMC. 
3.5. MTS Assay for Cell Viability 
The cell viability was examined by a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium (MTS) assay. Briefly, BMMC were seeded at a density of   
5  10
5 cells/mL in 96 well plates (Nunc, Denmark). Each batch of cells included a non-treated group 
as control. PE (100 or 1000 μg/mL) was then added to each well, after which the plates were incubated 
for 24 h at 37 °C under 5% CO2. Next, MTS solutions (5 mg/mL) were added to each well. Next, the 
optical density was read at 490 nm. The cytotoxicity was then calculated by subtracting the ratio of the 
mean absorbance value for treated cells over the mean absorbance value for untreated cells from one. 
3.6. Enzyme-Linked Immunosorbent Assay (ELISA) 
Cells were seeded at a density of 1  10
6 cells/mL in 24 well tissue culture plates and then 
pretreated with various concentrations of PE (100 or 1000 μg/mL) for 30 min prior to PMA (50 nM) 
plus A23187 (1 μM) stimulation. ELISA plates (Falcon, Becton Dickinson Labware) were then coated 
overnight at 4 °C with anti-mouse IL-6 antibody diluted in coating buffer (0.1 M carbonate, pH 9.5) 
and then washed three times with PBS containing 0.05% tween 20. Non-specific protein binding sites 
were then blocked by incubating the plates with assay diluent (PBS containing 10% FBS, pH 7.0) for 
at least 1 hour. Immediately following the incubation, each sample and IL-6 standard were added to 
the wells, after which the plates were incubated for 2 h. Next, working detector (biotinylated   Int. J. Mol. Sci. 2010, 11                 
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anti-mouse IL-6 monoclonal antibody and streptavidin-HRP reagent) was added to each well and the 
plates were incubated for an additional 1 h. Finally, substrate solution (tetramethylbenzidine: TMB) 
was added to the wells, after which the plates were then incubated in the dark for 30 min. Next, the 
reaction was stopped using stop solution (2NH3PO4) and the absorbance at 450 nm was then measured. 
All standards and samples were assayed in duplicate. 
3.7. Determination of Prostaglandin D2 (PGD2) Levels 
To measure the inhibitory activity of PE on COX-2, cells were suspended in enriched medium at  
1   10
6 cells/mL and preincubated with aspirin (10 g/mL) for 2 h to irreversibly inactivate any   
pre-existing COX-1. After washing, the BMMC were activated with PMA (50 nM) + A23187 (1 μM) 
at 37 °C for 2 h in the presence or absence of PE dissolved in PBS. All reactions were quenched by 
centrifugation at 890 g at 4 °C for 5 min. The supernatant and cell pellet were frozen immediately in 
liquid N2 and stored at -80 °C until needed for further analysis. Under these conditions, the   
COX-2-dependent phase of PGD2 generation reached 1.3 ng/10
6 cells. The data are reported as the 
arithmetic mean of triplicate determinations. 
3.8. Determination of Leukotriene C4 (LTC4) Levels 
BMMC suspended in enriched medium at 1  10
6 cells/mL were pretreated with PE for 30 min at  
37 °C and stimulated with PMA (50 nM) + A23187 (1 μM). After 15 min of stimulation, the 
supernatants were isolated for further analysis by enzyme immunoassay (EIA). LTC4 was determined 
using an EIA kit (Cayman Chemical, Ann Arbor, MI, USA) according to the manufacturer's 
instructions. Under the conditions employed, LTC4 reached 2.3 ng/10
6 cells. All data are the arithmetic 
means of triplicate determinations. 
3.9. Western Blot Analysis 
After activation with PMA (50 nM) + A23187 (1 μM), BMMC were washed once with 10 mM 
phosphate buffer (pH 7.4) containing 150 mM NaCl (PBS) and lysed in PBS containing 0.1% SDS and 
10 mM β-mercaptoethanol at 1  10
7 cells/mL. The lysate (1  10
5 cells equivalent) was applied to 
10% SDS-polyacrylamide gels. After running the gel, the protein bands were blotted onto 
nitrocellulose membranes (Schleicher and Schull, Dassel, Germany) using a semi-dry blotter 
(MilliBlot-SDE system, Millipore, Bedford, MA, USA) according to the manufacturer’s instructions. 
Membranes were then washed once with 10 mM Tris-buffered saline (TBS, pH 7.2) containing 0.1% 
tween-20 (TBS-T), and then blocked for 1 h in TBS-T containing 3% skim milk. After washing the 
membranes with TBS-T, an antibody directed against COX-2 was added at a dilution of 1:5000 in 
TBS-T. After incubation for 2 h followed by washing three times, membranes were treated for 1 h with 
horseradish peroxide-conjugated goat anti-rabbit IgG (Santa Cruz, CA, USA) (diluted to 1:7000) in 
TBS-T. The protein bands were visualized using an enhanced chemiluminesence (ECL) system 
(Amersham Corp., Newark, NJ, USA). 
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3.10. Assay of β-Hexosaminidase Release 
β-Hexosaminidase (β-Hex), a marker of mast cell degranulation, was quantitated by 
spectrophotometric analysis of p-nitrophenyl-2-acetamido-2-deoxy-β-D-glucopyranoside hydrolysis 
(Sigma, St. Louis, MO, USA). Briefly, after harvesting the supernatant, cells were lysed in the same 
volume of medium by three freeze/thaw cycles. Ten milliliters of the BMMC lysate or supernatant 
samples were mixed with 50 μL of β-Hex substrate solution (1.3 mg/mL p-nitrophenyl-2-acetamido-2-
deoxy-β-D-glucopyranoside in 100 mM sodium citrate, pH 4.5) in the wells of 96-well plate and then 
incubated at 37 °C for 90 min. The reaction was stopped by adding 140 μL of 0.2 M glycine-NaOH 
(pH 10.7). Absorbance was measured at 410 nm in a microplate reader. The percentage of β-Hex 
released into the supernatant was calculated by the following formula: [S/(S + P)]  100, where S and 
P are the β-Hex contents of the supernatant and cell pellet, respectively. 
3.11. Chromatography 
The chromatographic system consisted of a pump (Shimadzu LC-10AT VP) and a UV detector 
(Shimadzu LC-SPD-10A VP). A Shim-pack VP-ODS column (4.6  250 mm, Shimadzu) was used. 
An isocratic of CH3CN:CH3OH:H2O (11:11:8) was used as the mobile phase at a flow rate of   
1.0 mL/min. The HPLC was monitored at 254 nm. 
3.12. Statistical Analysis 
The data from the experiments are presented as the mean ± S.E.M. The level of statistical 
significance was determined by analysis of variance (ANOVA) followed by Dunnett's t-test for 
multiple comparisons. P values less than 0.05 were considered to be significant. 
4. Conclusions 
The conclusion of these investigations is that PE can exhibit inhibitory effects on PMA and 
A23187-induced IL-6, PGD2, LTC4 production and COX-2 protein expression in bone marrow-derived 
mast cells. Considering the results, PE could represent a new drug treatment for various allergic 
diseases. Therefore, further studies are necessary to examine its clinical application. 
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